1. Home
  2. CNM vs PODD Comparison

CNM vs PODD Comparison

Compare CNM & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Core & Main Inc.

CNM

Core & Main Inc.

HOLD

Current Price

$48.26

Market Cap

9.0B

ML Signal

HOLD

Logo Insulet Corporation

PODD

Insulet Corporation

HOLD

Current Price

$152.33

Market Cap

10.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNM
PODD
Founded
1996
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Durable Goods
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
10.3B
IPO Year
2021
2007

Fundamental Metrics

Financial Performance
Metric
CNM
PODD
Price
$48.26
$152.33
Analyst Decision
Buy
Buy
Analyst Count
11
21
Target Price
$61.55
$341.48
AVG Volume (30 Days)
2.8M
1.5M
Earning Date
06-09-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
8.45
N/A
EPS
0.57
1.30
Revenue
$7,647,000,000.00
$2,708,100,000.00
Revenue This Year
$4.89
$24.55
Revenue Next Year
$4.21
$19.18
P/E Ratio
$84.14
$121.33
Revenue Growth
2.77
30.73
52 Week Low
$43.96
$138.79
52 Week High
$67.18
$354.88

Technical Indicators

Market Signals
Indicator
CNM
PODD
Relative Strength Index (RSI) 47.47 50.10
Support Level $44.79 $141.67
Resistance Level $54.63 $161.35
Average True Range (ATR) 2.20 5.56
MACD -0.06 2.03
Stochastic Oscillator 24.33 62.03

Price Performance

Historical Comparison
CNM
PODD

About CNM Core & Main Inc.

Core & Main is a leading specialty distributor with a focus on water, wastewater, storm drainage, and fire protection products. The company provides solutions to municipalities, private water companies, and professional contractors across municipal, nonresidential, and residential end markets. The company's specialty products and services are used in the maintenance, repair, replacement, and construction of water and fire protection infrastructure.

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Share on Social Networks: